SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-17-021820
Filing Date
2017-11-06
Accepted
2017-11-06 16:25:53
Documents
51
Period of Report
2017-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q fprx-10q_20170930.htm 10-Q 1532299
2 EX-10.1 fprx-ex101_35.htm EX-10.1 46292
3 EX-10.2 fprx-ex102_300.htm EX-10.2 19086
4 EX-10.3 fprx-ex103_298.htm EX-10.3 14401
5 EX-10.4 fprx-ex104_299.htm EX-10.4 13095
6 EX-31.1 fprx-ex311_9.htm EX-31.1 8508
7 EX-31.2 fprx-ex312_6.htm EX-31.2 8504
8 EX-32.1 fprx-ex321_8.htm EX-32.1 5351
9 EX-32.2 fprx-ex322_7.htm EX-32.2 5244
10 GRAPHIC g20171106210941240344.jpg GRAPHIC 55217
11 GRAPHIC g20171106210934753343.jpg GRAPHIC 4715
12 GRAPHIC g20171106210935479210.jpg GRAPHIC 9609
  Complete submission text file 0001564590-17-021820.txt   4852853

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT fprx-20170930.xml EX-101.INS 1039517
14 XBRL TAXONOMY EXTENSION SCHEMA fprx-20170930.xsd EX-101.SCH 24839
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE fprx-20170930_cal.xml EX-101.CAL 41938
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE fprx-20170930_def.xml EX-101.DEF 67753
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE fprx-20170930_lab.xml EX-101.LAB 224254
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE fprx-20170930_pre.xml EX-101.PRE 162218
Mailing Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080
Business Address TWO CORPORATE DRIVE SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS INC (Filer) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36070 | Film No.: 171179739
SIC: 2834 Pharmaceutical Preparations